Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
Authors
Keywords
-
Journal
Immunotherapy
Volume 10, Issue 8, Pages 713-728
Publisher
Future Medicine Ltd
Online
2018-03-23
DOI
10.2217/imt-2017-0178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy
- (2017) Tanja M. Windegger et al. TRANSFUSION MEDICINE REVIEWS
- Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years
- (2017) R. Aguiar et al. ARTHRITIS CARE & RESEARCH
- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins
- (2017) Venkat Reddy et al. ARTHRITIS CARE & RESEARCH
- Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist
- (2016) David A. Khan ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
- (2016) Emilio Besada BMC MUSCULOSKELETAL DISORDERS
- Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
- (2016) Til Menge et al. Expert Review of Neurotherapeutics
- NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation
- (2016) Heidrun Boztug et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab
- (2016) Kalman Filanovsky et al. Recent Patents on Anti-Cancer Drug Discovery
- Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
- (2016) Til Menge et al. Expert Review of Neurotherapeutics
- Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions
- (2015) Md Yuzaiful Md Yusof et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- The expanding family of regulatory B cells
- (2015) Claudia Mauri et al. INTERNATIONAL IMMUNOLOGY
- Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab—for how long?
- (2015) Sara Barmettler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Practice parameter for the diagnosis and management of primary immunodeficiency
- (2015) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years
- (2015) R. F. van Vollenhoven et al. JOURNAL OF RHEUMATOLOGY
- Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study
- (2015) Federico De Angelis et al. LEUKEMIA RESEARCH
- Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
- (2014) Mathias Witzens-Harig et al. ANNALS OF HEMATOLOGY
- Profound symptomatic hypogammaglobulinemia: A rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
- (2014) Romain Levy et al. AUTOIMMUNITY REVIEWS
- The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
- (2014) Helena Marco et al. BMC MUSCULOSKELETAL DISORDERS
- Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients
- (2014) N. Compagno et al. HAEMATOLOGICA
- Rituximab
- (2014) Ulrich Storz mAbs
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement
- (2014) Sai S. Duraisingham et al. PLoS One
- Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes
- (2014) M. Makatsori et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
- (2014) Federico Alberici et al. RHEUMATOLOGY
- Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis
- (2014) Emilio Besada et al. RHEUMATOLOGY
- Rituximab and Immune Deficiency: Case Series and Review of the Literature
- (2014) Blanka Kaplan et al. Journal of Allergy and Clinical Immunology-In Practice
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Off-label use of rituximab in dermatology: pemphigus treatment
- (2013) Lislaine Bomm et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Safety and efficacy of90Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study
- (2013) Adalberto Ibatici et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complicated pathophysiology behind rituximab-induced persistent hypogammaglobulinemia
- (2013) Gen Kano et al. IMMUNOLOGY LETTERS
- Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
- (2013) S. Herter et al. MOLECULAR CANCER THERAPEUTICS
- Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Markus Bredemeier et al. ARTHRITIS CARE & RESEARCH
- Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies
- (2012) Ira V. Gupta et al. Annals of the New York Academy of Sciences
- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
- (2012) Carla Casulo et al. Clinical Lymphoma Myeloma & Leukemia
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Use of Combination Chemotherapy for Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Patients with Common Variable Immunodeficiency (CVID)
- (2012) Nicole M. Chase et al. JOURNAL OF CLINICAL IMMUNOLOGY
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
- (2012) Matthieu Mahévas et al. JOURNAL OF CLINICAL INVESTIGATION
- Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
- (2012) Laëtitia Delbe-Bertin et al. PEDIATRIC NEPHROLOGY
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
- (2012) Nils Venhoff et al. PLoS One
- Targeting B Cells and Antibody in Transplantation
- (2011) M. R. Clatworthy AMERICAN JOURNAL OF TRANSPLANTATION
- A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
- (2011) S. De Vita et al. ARTHRITIS AND RHEUMATISM
- The future of anti-CD20 monoclonal antibodies: are we making progress?
- (2011) W. Alduaij et al. BLOOD
- Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
- (2011) S. Audia et al. BLOOD
- Rituximab therapy for Type I membranoproliferative glomerulonephritis
- (2011) John J. Dillon et al. CLINICAL NEPHROLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
- (2010) F. C. Fervenza et al. Clinical Journal of the American Society of Nephrology
- Deciphering antibody-mediated rejection: new insights into mechanisms and treatment
- (2010) Mark D Stegall et al. Current Opinion in Organ Transplantation
- Human peripheral blood B-cell compartments: A crossroad in B-cell traffic
- (2010) M. Perez-Andres et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- (2010) Erika Irie et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- Rituximab in Severe Pemphigus
- (2009) Enno Schmidt et al. Annals of the New York Academy of Sciences
- Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients
- (2009) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Good and bad memories following rituximab therapy
- (2009) E. William St.Clair ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin
- (2009) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- PERSISTENT ANTIBODY DEPLETION AFTER RITUXIMAB IN THREE CHILDREN WITH AUTOIMMUNE CYTOPENIAS
- (2009) Mehdi Mohammad G. Adeli et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy
- (2008) E. Keystone et al. ARTHRITIS AND RHEUMATISM
- Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment
- (2008) Petra Roll et al. ARTHRITIS AND RHEUMATISM
- Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis
- (2008) Shouvik Dass et al. ARTHRITIS AND RHEUMATISM
- Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study
- (2008) B. Godeau et al. BLOOD
- Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT
- (2008) K Masjosthusmann et al. BONE MARROW TRANSPLANTATION
- Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma
- (2008) L K Hicks et al. BONE MARROW TRANSPLANTATION
- Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma
- (2008) Alison R. Walker et al. CANCER INVESTIGATION
- A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery
- (2008) Jennifer A. Sutter et al. CLINICAL IMMUNOLOGY
- Rituximab: Beyond Simple B Cell Depletion
- (2008) A. Kessel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
- (2008) Mitsufumi Nishio et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started